NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/walgreens-boots-a ...

Walgreens Boots Alliance has hired a firm to sell its stake in doctor-staffed clinic operator ... [+] VillageMD, which has already cost the drugstore giant billions of dollars.Walgreens Boots Alliance Walgreens Boots Alliance is getting closer to selling its stake in doctor-staffed clinic operator VillageMD, which has already cost the drugstore giant billions of dollars.Walgreens is working with the investment banking firm Evercore and the consulting firm Alvarez & Marsal as advisors in the sale, several ne ...

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=128954&from=4 CLASS ...

Walgreens Boots Alliance-backed healthcare clinic chain VillageMD is reportedly working with advisers to explore a sale, restructuring or other options.This move comes after Walgreens CEO Tim Wentworth said during a January earnings call that the company plans to divest VillageMD, Bloomberg reported Wednesday (Feb. 12).A Walgreens spokesperson told Bloomberg that Walgreens “is continuing to work toward executing its stated goal of securing an endpoint for its investment in VillageMD, consistent with Walgree ...

Walgreens is set to close five locations across Los Angeles and Orange counties in the coming weeks — a move that could result in at least 93 job losses as the struggling retailer moves ahead with a downsizing that will see around 1,200 closures nationwide.The pharmacy chain will shutter stores in Whittier, downtown Los Angeles, Orange, Placentia and Stanton, according to a notice submitted to California’s Employment Development Department.The store closures will lead to layoffs for a range of employees, in ...

Walgreens Boots Alliance (WBA -6.12%) faces an uncertain path ahead. Its financials haven't been strong in recent years, and its struggling pharmaceutical operations face growing competition. While it is slashing its store count, there's no surefire strategy that will turn the business around.Shares of the pharmacy retailer haven't been this low in decades. And while some investors may have been willing to just hang on to the stock amid the uncertainty and simply collect its dividend, now, even that is gone ...

I last analyzed Walgreens Boots Alliance (NASDAQ: WBA ) on 10-29-2024. In an article entitled "Walgreens Q4: 2 Signs Of A Dividend Trap," I rated the stock as a sell and cautioned readers of As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy ...

SAN DIEGO, Feb. 10, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) common stock between April 2, 2020 and January 16, 2025, inclusive (the "Class Period"), have until March 31, 2025 to seek appointment as lead plaintiff of the Walgreens class action lawsuit. Captioned Klein v. Walgreens Boots Alliance, Inc., No. 25-cv-01058 (N.D. Ill.), the Walgreens class action lawsuit charges Walgreens as well as ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Walgreens Boots Alliance, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from April 2, 2020, to January 16, 2025 [1] Allegations - The complaint alleges that Walgreens violated federal laws related to the dispensation of prescription medication and reimbursement, despite claiming a commitment to regulatory compliance [1] - It is claimed that the company's conduct would lead to increased regulatory scrutiny, civil liability, and reputational damage [1] - The revenues from prescription medication sales are said to be unsustainable due to their reliance on unlawful practices [1] - As a result, Walgreens' public statements during the class period are characterized as materially false and misleading [1] Next Steps for Shareholders - Shareholders who purchased WBA shares during the specified timeframe are encouraged to register for the class action by March 31, 2025, to potentially become lead plaintiffs [2] - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [2] About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit, fraud, and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [3]

Group 1: Stock Performance - Walgreens Boots Alliance (WBA) stock closed at $10.12, reflecting a +0.7% change from the previous trading day's closing, outperforming the S&P 500's daily loss of 0.95% [1] - The stock has increased by 9% over the past month, surpassing the Retail-Wholesale sector's gain of 7.69% and the S&P 500's gain of 1.86% [1] Group 2: Earnings Forecast - The upcoming earnings report is expected to show an EPS of $0.53, indicating a 55.83% decrease from the same quarter last year [2] - The Zacks Consensus Estimate for revenue is projected at $38.07 billion, which is a 2.75% increase from the previous year [2] Group 3: Annual Estimates - For the annual period, earnings are anticipated to be $1.60 per share, reflecting a -44.44% change from last year, while revenue is expected to be $151.57 billion, indicating a +2.65% change [3] Group 4: Analyst Estimates - Recent adjustments to analyst estimates for Walgreens Boots Alliance are important as they reflect changes in short-term business dynamics, with positive revisions indicating analysts' confidence in the company's performance [4] Group 5: Zacks Rank and Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has shown a strong track record, with stocks rated 1 producing an average annual return of +25% since 1988 [6] - Walgreens Boots Alliance currently holds a Zacks Rank of 3 (Hold), with a 5.59% rise in the Zacks Consensus EPS estimate over the past month [6] Group 6: Valuation Metrics - Walgreens Boots Alliance has a Forward P/E ratio of 6.28, which is higher than the industry average of 4.72, indicating it is trading at a premium [7] - The company has a PEG ratio of 1.26, compared to the industry average PEG ratio of 0.72, suggesting a higher expected earnings growth rate relative to its peers [8] Group 7: Industry Ranking - The Retail - Pharmacies and Drug Stores industry, part of the Retail-Wholesale sector, holds a Zacks Industry Rank of 87, placing it in the top 35% of over 250 industries [8] - The strength of individual industry groups is measured by the Zacks Industry Rank, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [9]